spritze

J&J: Risiko lebendsbedrohlicher Lähmungen (Guillain-Barré-Syndrom) bei 1/3000 ?

 

 

Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink | Clinical Pharmacy and Pharmacology | JAMA Network Open | JAMA Network

This cohort study investigates cases and incidence of Guillain-Barré syndrome following COVID-19 vaccination and assesses the risk of GBS after vaccination with